Indivior Pharmaceuticals, Inc. (INDV) Market Cap
- 2026-09-03: Market Cap $4.11B.
- 2026-07-28: Market Cap $4.84B.
- 2026-04-01: Market Cap $3.74B.
- 2026-01-31: Market Cap $4.42B.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2023-12-31 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|---|
| 2026-09-03 | $4.11B |
| 2026-07-28 | $4.84B |
| 2026-04-01 | $3.74B |
| 2026-01-31 | $4.42B |
| 2025-10-01 | $2.93B |
| 2025-07-01 | $1.83B |
| 2025-05-01 | $1.44B |
| 2025-03-01 | $1.15B |
| 2023-12-31 | $2.08B |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |